Companies: 10,795·Total market cap: $144.5T
Alpha Healthcare Acquisition Corp. III

Alpha Healthcare Acquisition Corp. III

ALPANASDAQFinancial Services
$9.80
+$0.01(+0.10%)
Market Cap$193736200
P/E Ratio
52W High$11.83
52W Low$8.73

Alpha Healthcare Acquisition Corp. III (ALPA) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

alpa · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Alpha Healthcare Acquisition Corp. III (ALPA) measures how much investors pay for each dollar of the company's trailing earnings. ALPA's current PE ratio of N/A is calculated by dividing its stock price of $9.80 by its TTM earnings per share of -$3.60.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
-$3.60
TTM · diluted EPS
PEG Ratio
-0.03
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Alpha Healthcare Acquisition Corp. III SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 956.4x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Shell Companies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Alpha Healthcare Acquisition Corp. III
Alpha Healthcare Acquisition Corp. IIIYou
ALPA
$194MN/A-$3.60
AxonPrime Infrastructure Acquisition Corporation
AxonPrime Infrastructure Acquisition Corporation
APMI
$194MN/A
ARYA Sciences Acquisition Corp V
ARYA Sciences Acquisition Corp V
ARYE
$199M11.48x-95.9%$0.88
BioPlus Acquisition Corp.
BioPlus Acquisition Corp.
BIOS
$209M1183.31x+325.8%$0.01
FACT II Acquisition Corp
FACT II Acquisition Corp
FACT
$259M38.36x-86.2%$0.27
Galata Acquisition Corp.
Galata Acquisition Corp.
GLTA
$193M143.41x-48.4%$0.07
G Squared Ascend II Inc.
G Squared Ascend II Inc.
GSQB
$188M13.02x-95.3%$0.78
Industry Average
5 peers with valid PE
277.92xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-4.83
2024-12-31
FY2024
$-0.06
2022-12-31
FY2022
956.38x$0.01
2021-12-31
FY2021
$-0.03

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Alpha Healthcare Acquisition Corp. III (ALPA) measures how much investors pay for each dollar of the company's trailing earnings. ALPA's current PE ratio of N/A is calculated by dividing its stock price of $9.80 by its TTM earnings per share of -$3.60.

PE Ratio = Stock Price ÷ EPS (TTM)
= $9.80 ÷ -$3.60 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ALPA pe ratio · 6 questions

ALPA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $9.80 and TTM EPS of -$3.60. Data sourced from Financial Modeling Prep via ALPA's SEC 10-K and 10-Q filings.

ALPA PE ratioWhat is ALPA PE ratioCurrent PE ratio of ALPAALPA PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Alpha Healthcare Acquisition Corp. III SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09